FDA meeting to evaluate COVID-19 vaccines for children as young as six months
June 16 2022, 08:00
The Food and Drug Administration is poised to approve the Pfizer and Moderna vaccines for children as young as six months on Wednesday, the final age group to receive approval.
The Food and Drug Administration is poised to approve the Pfizer and Moderna vaccines for children as young as six months on Wednesday, the final age group to receive approval.
Source:
FOX News
